Clinical trial
Towards Reducing Resistance and Hematological Toxicity of Linezolid
NCT00177723 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177723 |
|---|---|
| Title | Towards Reducing Resistance and Hematological Toxicity of Linezolid |
| Official title | Towards Reducing Resistance and Hematological Toxicity of Linezolid |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Monash University |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection, Adverse Effects |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: